Gottlieb calls out ‘rigged’ system that’s hurting biosimilars, pledges FDA fight to boost uptake

As biosimilars struggle in the U.S. market and much of their potential savings go unrealized, the issue is getting attention from a top health official. On Wednesday, FDA Commissioner Scott Gottlieb blasted a "rigged" contracting system that's hurting uptake and development, pledging agency action to do what it can to amend the situation.Original Article